Until recently, metformin was considered the only first-line agent to treat type 2 diabetes, either alone or in combination with other anti-diabetic medications
GLP-1s stimulate the production of insulin to reduce blood sugar, slow the digestion process, reduce appetite, and signal fullness
Side effects were common in treatment arm, and significantly more pronounced than in placebo groups (44% reported nausea)
The normal ducts, however, lack GLP1R and are therefore not a likely target for GLP1 analogs
Probiotics supplementation and insulin resistance: a systematic review
Low immediate postoperative platelet count is associated with hepatic insufficiency after hepatectomy